![Theo Melas-Kyriazi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Theo Melas-Kyriazi
Directeur/Membre du Conseil chez InterAx Biotech AG
Provenance du réseau au premier degré de Theo Melas-Kyriazi
Entité | Type d'entité | Industrie | |
---|---|---|---|
InterAx Biotech AG
![]() InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services InterAx Biotech AG engages in assisting drug candidate design and selection. It focuses on the development of its systems biology platform. The company was founded by Martin Ostermaier, Aurelien Rizk, and Luca Zenone and is headquartered in Villigen, Switzerland.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Theo Melas-Kyriazi via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
BioRexis Pharmaceutical Corp.
![]() BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Pharmaceuticals: Major | Founder | |
Eulitha AG
![]() Eulitha AG SemiconductorsElectronic Technology Eulitha AG produces nanostructures using advanced lithography techniques. Its products include standard patterns, custom nano patterning, EUV gratings and phabler 100. The company was founded by Jens Gobrecht and Harun H. Solak in 2006 and is headquartered in Kirchdorf, Switzerland. | Semiconductors | Founder | |
Synendos Therapeutics AG
![]() Synendos Therapeutics AG Medical SpecialtiesHealth Technology Synendos Therapeutics AG develops molecules for the treatment of anxiety and stress-related disorders. The company was founded by Andrea Chicca, Simon Russell and Jürg Gertsch in April 2019 and is headquartered in Allschwil, Switzerland. | Medical Specialties | Director/Board Member | |
Sandoz Biopharmaceuticals | Corporate Officer/Principal | ||
The University of Newcastle | College/University | Undergraduate Degree | |
University of Cambridge | College/University | Doctorate Degree | |
ALVOTECH | Biotechnology | Chief Executive Officer | |
Alvotech hf
![]() Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Pharmaceuticals: Major | Chief Executive Officer | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
New York Academy of Sciences
![]() New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of London | College/University | Undergraduate Degree | |
9 METERS BIOPHARMA, INC. | Biotechnology | Chief Executive Officer | |
Principia Pharmaceutical Corp
![]() Principia Pharmaceutical Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Principia Pharmaceutical Corp is a derivatives industry analysis company that examines valuation, risk management, and operational requirements for derivatives end users. The company is based in Norristown, PA. Principia Pharmaceutical was acquired by Human Genome Sciences, Inc., part of GSK Plc from August 03, 2012 on September 11, 2000 for $120 million. The company also provides fixed income and structured credit investor research and whitepaper downloads. The company was founded by Christopher P. Prior. | Pharmaceuticals: Major | Founder | |
Orchestra Therapeutics, Inc.
![]() Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Financial Conglomerates | Corporate Officer/Principal | |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal | |
PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
Acthera Therapeutics AG
![]() Acthera Therapeutics AG BiotechnologyHealth Technology Acthera Therapeutics AG is a Swiss biotechnology company that develops synthetic lipid membrane vesicles. The private company is based in Basel, Switzerland. The CEOs are Carlo Bertozzi, Pierre-Alain Monnard. The company was founded by Roger Meier. | Biotechnology | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 10 |
Suisse | 5 |
Royaume-Uni | 3 |
France | 2 |
Australie | 2 |
Sectorielle
Health Technology | 12 |
Consumer Services | 5 |
Electronic Technology | 2 |
Commercial Services | 2 |
Finance | 2 |
Opérationnelle
Director/Board Member | 10 |
Chief Executive Officer | 6 |
Founder | 5 |
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 3 |
Relations les plus connectées
Insiders | |
---|---|
Christopher P. Prior | 12 |
Mark Levick | 7 |
Bettina Ernst | 3 |
Jens Gobrecht | 2 |
Luca Zenone | 1 |
Aurélien Rizk | 1 |
Yiannis Monovoukas | 1 |
- Bourse
- Insiders
- Theo Melas-Kyriazi
- Connexions Sociétés